Načítá se...
Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
Background: Esophagogastric junction tumor (EGJ) is a rare but fatal disease with a rapid rising incidence worldwide in the late 20 years, and it lacks a convenient and safe method for diagnosis. The present study aimed to evaluate the potential of serum CYR61 as a biomarker for the diagnosis of EGJ...
Uloženo v:
| Vydáno v: | Biosci Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Portland Press Ltd.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8217984/ https://ncbi.nlm.nih.gov/pubmed/34085702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20204117 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|